Post-approval studies (Phase 4)Study completedNCT00625274
What this trial is testing
A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients
Who this might be right for
HeartburnUpper Abdominal PainNausea+1 more
AstraZeneca 100